glp 1 and parkinson's The Emerging Role of GLP-1 RAs in Disease BQURA | R&D News -

Headlines are running that millions more people should be taking statins

Herein, we successfully switched a patient with acromegaly from a dipeptidyl peptidase-4 (DPP-4) inhibitor to a glucagon-like peptide-1 (GLP-1) analog due to pasireotide-induced deterioration of glycemic control, and we examined the underlying mechanism for glycemic control

While their glycemic, weight-lowering, and cardiovascular benefits are well established through randomized trials and meta-analyses, concerns remain regarding their safety and tolerability across diverse populations and clinical settings

Energy on track

Unlike stimulant-based appetite suppressants, Calocurb is free from caffeine, artificial fillers, or additives, making it a natural, science-backed solution for managing food cravings and calorie consumption